Video
Identifying, Assessing the Most Common Cancer Treatment Complications That Can Lead to Oncologic Emergencies
Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains what the most common complications from cancer treatment are that can lead to oncologic emergencies and how can they be identified.
Pharmacy Times interviewed Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, on her presentation at the 2021 National Pharmaceutical Association conference, titled Oncologic Emergencies: Recognition & Initial Management.
During this discussion, Below explained what the most common complications from cancer treatment are that can lead to oncologic emergencies and how can they be identified. She also discussed how the use of newer immunologic therapies can lead to complications from cancer treatment and some potential approaches to address this issue.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa
